Physiological Levels of Tumstatin, a Fragment of Collagen IV Alpha3 Chain, Are Generated by MMP-9 Proteolysis and Suppress Angiogenesis Via AlphaV Beta3 Integrin

Overview

Journal Cancer Cell

Publisher Cell Press

Specialty Oncology

Date 2003 Jul 5

PMID 12842087

Citations 199

Authors

Yuki Hamano

Michael Zeisberg

Hikaru Sugimoto

Julie C Lively

Yohei Maeshima

Changqing Yang

Richard O Hynes

Zena Werb

Akulapalli Sudhakar

Raghu Kalluri

Affiliations

Soon will be listed here.

Abstract

We demonstrate a physiological role for tumstatin, a cleavage fragment of the alpha3 chain of type IV collagen (Col IValpha3), which is present in the circulation. Mice with a genetic deletion of Col IValpha3 show accelerated tumor growth associated with enhanced pathological angiogenesis, while angiogenesis associated with development and tissue repair are unaffected. Supplementing Col IValpha3-deficient mice with recombinant tumstatin to a normal physiological concentration abolishes the increased rate of tumor growth. The suppressive effects of tumstatin require alphaVbeta3 integrin expressed on pathological, but not on physiological, angiogenic blood vessels. Mice deficient in matrix metalloproteinase-9, which cleaves tumstatin efficiently from Col IValpha3, have decreased circulating tumstatin and accelerated growth of tumor. These results indicate that MMP-generated fragments of basement membrane collagen can have endogenous function as integrin-mediated suppressors of pathologic angiogenesis and tumor growth.

Citing Articles

Circulating Podocalyxin, Tumstatin/Col-IVα3 and Chitinase 1: New Culprits in Vitiligo Occurrence.

Gencoglu S Dermatol Pract Concept. 2024; 14(1).

PMID: 38236996 PMC: 10868821. DOI: 10.5826/dpc.1401a95.

Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review.

Mesgari H, Esmaelian S, Nasiri K, Ghasemzadeh S, Doroudgar P, Payandeh Z Cancers (Basel). 2023; 15(23).

PMID: 38067304 PMC: 10705512. DOI: 10.3390/cancers15235600.

CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents.

Lee D, Imran M, Choi J, Park Y, Kim Y, Min S Mol Oncol. 2023; 18(1):216-232.

PMID: 37854019 PMC: 10766199. DOI: 10.1002/1878-0261.13541.

Matrikines in kidney ageing and age-related disease.

Eckersley A, Yamamura T, Lennon R Curr Opin Nephrol Hypertens. 2023; 32(6):551-558.

PMID: 37584348 PMC: 10552846. DOI: 10.1097/MNH.0000000000000916.

Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications.

Das S, Dash B, Premji T, Chen J Int J Mol Sci. 2023; 24(13).

PMID: 37445721 PMC: 10341481. DOI: 10.3390/ijms241310546.

References

Hynes R . A reevaluation of integrins as regulators of angiogenesis. Nat Med. 2002; 8(9):918-21. DOI: 10.1038/nm0902-918. View

Ortega N, Werb Z . New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci. 2002; 115(Pt 22):4201-14. PMC: 2789001. DOI: 10.1242/jcs.00106. View

Hynes R, Lively J, McCarty J, Taverna D, Francis S, Hodivala-Dilke K . The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harb Symp Quant Biol. 2003; 67:143-53. DOI: 10.1101/sqb.2002.67.143. View

Kalluri R . Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis. Cold Spring Harb Symp Quant Biol. 2003; 67:255-66. DOI: 10.1101/sqb.2002.67.255. View

Hogemann B, Voss B, Pott G, Rauterberg J, Gerlach U . 7 S collagen: a method for the measurement of serum concentrations in man. Clin Chim Acta. 1984; 144(1):1-10. DOI: 10.1016/0009-8981(84)90254-7. View

Madri J, Pratt B . Endothelial cell-matrix interactions: in vitro models of angiogenesis. J Histochem Cytochem. 1986; 34(1):85-91. DOI: 10.1177/34.1.2416801. View

Maragoudakis M, Missirlis E, Karakiulakis G, Sarmonica M, Bastakis M, Tsopanoglou N . Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties. Kidney Int. 1993; 43(1):147-50. DOI: 10.1038/ki.1993.24. View

Reddy G, Gunwar S, Kalluri R, Hudson B, NOELKEN M . Structure and composition of type IV collagen of bovine aorta. Biochim Biophys Acta. 1993; 1157(3):241-51. DOI: 10.1016/0304-4165(93)90106-i. View

Hudson B, Reeders S, Tryggvason K . Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem. 1993; 268(35):26033-6. View

10.

Zhang X, Hudson B, Sarras Jr M . Hydra cell aggregate development is blocked by selective fragments of fibronectin and type IV collagen. Dev Biol. 1994; 164(1):10-23. DOI: 10.1006/dbio.1994.1176. View

11.

Derry C, Pusey C . Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting. Nephrol Dial Transplant. 1994; 9(4):355-61. View

12.

OReilly M, Holmgren L, Shing Y, Chen C, Rosenthal R, Moses M . Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994; 79(2):315-28. DOI: 10.1016/0092-8674(94)90200-3. View

13.

Yurchenco P, ORear J . Basal lamina assembly. Curr Opin Cell Biol. 1994; 6(5):674-81. DOI: 10.1016/0955-0674(94)90093-0. View

14.

Gabrielli A, Marchegiani G, Rupoli S, Ansuini G, Brocks D, Danieli G . Assessment of disease activity in essential cryoglobulinemia by serum levels of a basement membrane antigen, laminin. Arthritis Rheum. 1988; 31(12):1558-62. DOI: 10.1002/art.1780311214. View

15.

Tsilibary E, Reger L, Vogel A, Koliakos G, Anderson S, Charonis A . Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen. J Cell Biol. 1990; 111(4):1583-91. PMC: 2116235. DOI: 10.1083/jcb.111.4.1583. View

16.

Gunwar S, Ballester F, Kalluri R, Timoneda J, Chonko A, Edwards S . Glomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen. J Biol Chem. 1991; 266(23):15318-24. View

17.

Paulsson M . Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol. 1992; 27(1-2):93-127. DOI: 10.3109/10409239209082560. View

18.

Yudoh K, Matsui H, Kanamori M, Ohmori K, Tsuji H, Tatezaki S . Serum levels of laminin, type IV collagen and type III procollagen peptide as markers for detection of metastasis. Jpn J Cancer Res. 1994; 85(12):1263-9. PMC: 5919399. DOI: 10.1111/j.1349-7006.1994.tb02939.x. View

19.

Kuhn K . Basement membrane (type IV) collagen. Matrix Biol. 1995; 14(6):439-45. DOI: 10.1016/0945-053x(95)90001-2. View

20.

Prockop D, Kivirikko K . Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem. 1995; 64:403-34. DOI: 10.1146/annurev.bi.64.070195.002155. View